Click the “Start Activity” button to indicate you have reviewed the CME information for this activity.
Activity Speakers
Ashish M. Kamat, MD
Professor of Urology
Wayne B. Duddlesten Professorship in Cancer Research
Attending Surgeon, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, Texas
Peter Black, MD
Senior Research Scientist
Vancouver Prostate Centre
Professor, Department of Urologic Sciences
University of British Columbia
Vancouver, BC, Canada
Estimated Course Time: 1 Hour
Release Date: April 27, 2o18
Expiration Date: April 27, 2019
Program Overview
The goal of this educational program is to equip urologists, medical oncologists, radiation oncologists, and other healthcare providers nationwide who are involved in the treatment of patients with bladder cancer with the up-to-date clinical knowledge and tools they need to best diagnose and treat their patients. With growing advancements in immunotherapy treatment of bladder cancer, patients may experience better treatment outcomes.
Learning Objectives
- Recognize the role of the immune system in cancer development and resisting carcinogenesis
- Describe the mechanism of action of immunotherapy options compared to other therapeutic treatments in bladder cancer
- Assess clinical data on different immunotherapy options and their implications on therapy decision making in bladder cancer treatment
- Identify the emerging role of biomarkers for immunotherapy treatment in bladder cancer
Target Audience
This activity has been developed and is intended and designed for urologists, medical oncologists, radiation oncologists, and other healthcare providers involved in the treatment of patients with bladder cancer.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME through the joint providership of the Medical College of Wisconsin and CJP. MCW is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity is accredited until April 27, 2019.
Disclosure of Conflict of Interest
It is the policy of the Medical College of Wisconsin to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, the MCW identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of the activity. Conflicts are resolved by MCW to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Click the “Start Activity” button to indicate you have reviewed the CME information for this activity.